Truist Financial Corp bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,710 shares of the company's stock, valued at approximately $257,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Clarkston Capital Partners LLC boosted its position in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock valued at $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Nuance Investments LLC increased its position in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. raised its stake in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Henry Schein in the third quarter worth approximately $515,000. Finally, Private Management Group Inc. boosted its holdings in Henry Schein by 5.7% in the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after acquiring an additional 18,882 shares in the last quarter. Institutional investors own 96.62% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on HSIC shares. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $81.10.
Get Our Latest Analysis on HSIC
Henry Schein Stock Up 2.2 %
Shares of HSIC traded up $1.63 during trading hours on Friday, reaching $74.59. 2,145,365 shares of the stock traded hands, compared to its average volume of 1,490,193. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a fifty day simple moving average of $74.57 and a 200 day simple moving average of $72.57. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a market cap of $9.26 billion, a price-to-earnings ratio of 30.70, a PEG ratio of 2.13 and a beta of 0.90.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 earnings per share. On average, equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.